Clinical Trials Logo

Filter by:
NCT ID: NCT03693183 Withdrawn - Dry Eye Clinical Trials

Efficacy Study of Ketorolac and HPMC to Treat Dry Eye

Start date: March 2009
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether ketorolac and Hydroxypropyl Methylcellulose are effective in the treatment of Dry Eye.

NCT ID: NCT03692221 Withdrawn - Disc Degeneration Clinical Trials

Mesenchymal Stem Cells for Lumbar Degenerative Disc Disease

Start date: June 2019
Phase: Early Phase 1
Study type: Interventional

This study seeks to bridge these technologies and obtain data regarding the safety and efficacy of image guided percutaneous needle injection of expanded autologous bone marrow derived mesenchymal stem cells to symptomatic degenerated intervertebral discs in humans. The primary outcome will be to assess the safety and efficacy and monitor for adverse events.

NCT ID: NCT03688568 Withdrawn - Clinical trials for Neurofibroma, Plexiform

Study of Imatinib in Children With Neurofibromatosis and Airway Tumors

Start date: September 1, 2018
Phase: Phase 2
Study type: Interventional

The purpose of this study is to look at a subset of plexiform neurofibromas and determine if the airway tumors are more sensitive to imatinib therapy. Funding Source - FDA OOPD

NCT ID: NCT03688477 Withdrawn - Clinical trials for Anterior Cruciate Ligament Reconstruction

Iovera° to Treat Pain Associated With ACL Reconstruction and Rehabilitation

Start date: October 2018
Phase: N/A
Study type: Interventional

To evaluate the outcomes of patients undergoing iovera° treatment of the ISN and AFCN on postoperative knee pain and function following anterior cruciate ligament reconstruction

NCT ID: NCT03688308 Withdrawn - Rotator Cuff Tear Clinical Trials

Bone Marrow Derived Stem Cells for the Treatment of Rotator Cuff Tears

Start date: January 1, 2020
Phase: N/A
Study type: Interventional

The primary objective is to determine whether adjunct treatment using bone marrow aspirate concentrate (BMAC) in conjunction with arthroscopic repair of rotator cuff tears reduces retear rates compared to a control population undergoing arthroscopic repair without BMAC administration. The secondary objectives are to (1) evaluate the survival and incorporation of BMAC labeled cells with MRI imaging using the Ferumoxytol infusion stem cell labeling technique, and (2) determine if administration of BMAC leads to better clinical outcomes as measured by ASES, UCLA and Constant scoring metrics.

NCT ID: NCT03687697 Withdrawn - Infertility Clinical Trials

Comparison of Global, G-TL, & Cornell Media

Start date: April 1, 2018
Phase: Phase 4
Study type: Interventional

This is a prospective, randomized clinical trial to compare the Global commercial single step media to 1) G-TL (Vitrolife), 2) Weill Cornell's single step and sequential steps media, which all support human embryo development in the laboratory using the Vitrolife Time-Lapse system. The main goal of the study is to identify the best culture medium for optimal embryo development.

NCT ID: NCT03685773 Withdrawn - Clinical trials for Diabetes Mellitus, Type 2

The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant Recipients

Start date: April 21, 2019
Phase: Phase 2
Study type: Interventional

It is believed that important brain centers send signals through the vagus nerve to the liver to suppress the amount of glucose (sugar) that gets produced. People who have received liver transplants have had their vagus nerve cut during transplantation, and many of these individuals have diabetes at one year post-transplant. The goals of this study are: to see whether metabolic control centers in the brain can still be activated normally with the medication diazoxide in patients who have had a liver transplant, and to understand whether disrupting the vagus nerve would result in excess glucose being produced by the liver (ie. a potential mechanism for why these patients develop diabetes).

NCT ID: NCT03682744 Withdrawn - Breast Cancer Clinical Trials

CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC)

Start date: September 13, 2018
Phase: Phase 1
Study type: Interventional

This is an open-label, dose-escalation, phase I trial of the safety and efficacy of anti-CEA intraperitoneal CAR-T infusions for treatment in patients with CEA-expressing adenocarcinoma peritoneal metastases or malignant ascites.

NCT ID: NCT03680976 Withdrawn - Asthma Clinical Trials

Anti-Inflammatory Lipid Mediators in Asthma

ALMA
Start date: n/a
Phase: Phase 2
Study type: Interventional

The purpose of this study is to demonstrate the efficacy and safety of 10-nitro-9(E)-octadec-9-enoic acid (CXA-10) in obese adult asthmatics. The study's hypothesis is that 150 mg/day of CXA-10 for 12 weeks will alleviate obesity-related airway hyper-reactivity in obese adult asthmatics.

NCT ID: NCT03679845 Withdrawn - Clinical trials for Morphea, Plaque Form

Study to Assess Sarilumab in Halting Progression of Morphea

Start date: September 1, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

An open-label single center trial studying the efficacy and safety of sarilumab on morphea patients.